Survey on COVID-19 impact in patients with primary immune deficiency

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather data on the effects of COVID-19 on individuals diagnosed with primary immune deficiencies (PID). It follows an initial phase that assessed the number of affected PID patients and the impact of SARS-CoV-2 on this vulnerable population. The survey is conducted through a secure online platform, ensuring compliance with GDPR regulations, and is approved by the relevant ethics committee. The goal is to better understand the outcomes and consequences of COVID-19 in patients with PID.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed with a Primary Immune Deficiency
* COVID-19 (proven or probable)

Exclusion Criteria:

* Secondary Immune Deficiency
* Other Coronovirus infection

Where it's running

• Imagine Institute
  Paris, France Recruiting

Study contacts

• Study coordinator: Nizar MAHLAOUI, MD, MPH, PhD
• Email: nizar.mahlaoui@aphp.fr
• Phone: +33144494622

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effects of suctioning on pain and stress in intubated ICU patients

  This study is testing if suctioning the breathing tube in ICU patients causes more pain and stress compared to not suctioning.

  Recruiting Loma Linda University · Loma Linda, California · NCT06692400

• Biorepository for patients receiving biologic therapy at Mount Sinai

  This study is collecting health information from patients receiving biologic therapy at Mount Sinai to help improve treatments for various immune-related diseases.

  Recruiting Icahn School of Medicine at Mount Sinai · New York, New York · NCT04784364

• New treatments for COVID-19 using nitazoxanide and ivermectin

  This study is testing if the medications nitazoxanide and ivermectin, alone or with other drugs, can help people with COVID-19 feel better.

  Recruiting at 2 sites Phase 3 Tanta University · Tanta and 1 other locations · NCT04382846

• Understanding the long-term effects of COVID-19 infection

  This study looks at people who have recovered from COVID-19 to see how the infection affects their health over time.

  Recruiting University of California, San Francisco · San Francisco, California · NCT04362150

• Evaluating higher doses of Ivermectin for COVID-19 treatment

  This study is testing whether higher doses of Ivermectin can help people with COVID-19 feel better and recover faster.

  Recruiting Phase 2/3 Tanta University · Tanta · NCT04351347

• Chilblain-like skin changes during COVID-19 infection

  This observational study looks at people with COVID-19 who develop skin lesions that look like chilblains to see what these sores have in common and what they might mean for the disease overall.

  Recruiting Centre Hospitalier Universitaire de Nice · Nice · NCT04344119

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.